Last reviewed · How we verify

NCT07245472

The Treatment of Shoulder-hand Syndrome in Hemiplegia Patients

Completed NA Last updated 24 November 2025
What this trial tests

NA trial testing Dry Needling in Shoulder-hand Syndrome in 84 participants. Completed in 1 October 2024.

Timeline
1 November 2023
Primary endpoint
1 October 2024
1 October 2024

Quick facts

Lead sponsorHandan Central Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment84
Start date1 November 2023
Primary completion1 October 2024
Estimated completion1 October 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Handan Central Hospital

Who can join

Adults 40 to 80, any sex, with Shoulder-hand Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical study is to investigate effects of Kinesio taping (KT) combined with dry needling (DN) on myofascial trigger points (MTrPs) in post-stroke hemiplegic shoulder-hand syndrome (SHS). Methods: A prospective, double-blind randomized controlled trial was conducted on 84 SHS patients, who were randomized into three groups: DN (Group A), KT (Group B), and DN+KT (Group C), all receiving standard rehabilitation. VAS, ADL, FMA-UE, PROM, and 8-figure dimensional difference were assessed pre- and post-28-day treatment. Statistical analysis was performed using SPSS 27.0, with paired t-test for intragroup comparisons and independent sample t-test for intergroup comparisons, and statistical significance was set at P\<0.05.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dry Needling

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07245472.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing